Financial Daily from THE HINDU group of publications
Thursday, Jul 29, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Marketing - Strategy
Corporate - Alliances & Joint Ventures


GlaxoSmithKline arm in marketing pact with Honeywell Burdick

Our Bureau

Mumbai , July 28

QUALIGENS Fine Chemicals (QFC), a division of GlaxoSmithKline (GSK) India, that manufactures and markets research and laboratory chemicals and lab-ware has inked a marketing agreement with Honeywell Burdick & Jackson.

QFC would now market Honeywell Burdick & Jackson (B&J) high purity solvents to India, Nepal and Bhutan, a GSK communiqué said here today. GSK India will provide sales and logistics to bring these products to its broad pharmaceutical and biotechnology customer base in the said markets. High-purity solvents are critical to the successful research, development and approval cycle of pharmaceutical products.

More Stories on : Strategy | Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
GlaxoSmithKline arm in marketing pact with Honeywell Burdick


Ayush mulls global foray; exports in the pipeline
Pepsi bottler Jaipuria to cut exposure in soft drinks — To foray into beer market; snaps up brewery in Mauritius
Kingfisher Air to have models as air hostesses
Dr Reddy's alters business strategy for US — To focus on specialty segments
Electrolux marketing drive in Kerala
1pointsize bags NY Festivals nominations
SBI Aadi offer gets big response
5-year Seagate warranty
TQ3 India eyes bigger share of corporate travel market
Organised retail sector seeks industry status
Idea, Hutch launch hi-speed data services
AMP Sanmar launches unit-linked plan
New HP workstations



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line